QuickView for Snu114;jsessionid=E6CFEBF89F5D3CDF30ECF83CD1C05944;jsessionid=D8C328B2E39C75604DFC59E5E99586BA;jsessionid=D5700A1E2A52B7E948D729984F963023;jsessionid=47B636465AF2FA2FF1367298CAFA731B (gene)

1. Atypical mandibulofacial dysostosis with microcephaly diagnosed through the identification of a nove…
2. High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer.
3. The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcriptio…
4. The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing.
5. A de novo start-loss in EFTUD2 associated with mandibulofacial dysostosis with microcephaly: case re…

There were no clinical trials for Snu114;jsessionid=E6CFEBF89F5D3CDF30ECF83CD1C05944;jsessionid=D8C328B2E39C75604DFC59E5E99586BA;jsessionid=D5700A1E2A52B7E948D729984F963023;jsessionid=47B636465AF2FA2FF1367298CAFA731B